Search results
Conduction System Pacing: A Fresh Look
Video Series
Start date:
May 09, 2026
End date:
May 12, 2026
ESC Heart Failure Congress 2026 (Heart Failure 2026), organised by the Heart Failure Association of the European Society of Cardiology (ESC), will take place from 9–12 May 2026 in Barcelona, Spain. Under the theme “Evolution in Heart Failure”, the congress focuses on transforming discovery into impact, advancing prevention, precision diagnosis and treatment of heart failure worldwide.Who should…
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof John Cleland, Prof Gerasimos Filippatos, Prof Ewa Jankowska, Prof David Wheeler, Dr Kieran Docherty discuss anaemia and iron deficiency.
View more
Added:
11 months ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,…
View more
Added:
5 months ago
Added:
1 year ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different…
View more
Added:
1 year ago
HFA 2024 — Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Mark Petrie (University of Glasgow, UK) for an insightful wrap up of the novel data presented at 2024's Heart Failure Congress.00:24 - STEP HFpEF Programme: Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF & Semaglutide therapy and diuretic use in obesity-related HFpEF02:20 - EMPACT-MI: The effect of…
View more
An Expert Approach to Cardio-Renal Protection in CKD
Video Series
Added:
5 months ago
Source:
Radcliffe Cardiology
Observational studies have long suggested that women who experience hypertensive disorders of pregnancy (HDP) face a greater risk of cardiovascular disease (CVD) later in life. A new genetic epidemiological study has explored whether this association is causal, using Mendelian randomization (MR) to investigate the genetic underpinnings of this risk. The findings suggest a genetic predisposition…
View more
Added:
6 months ago
EASD Congress 2025 - Dr Camilla Andersen (The University of Western Australia, Perth, AU) joins us to discuss findings from the EMPIRE-PREVENT: Metabolic study, investigating the metabolic effects of empagliflozin in elderly and obese patients at high risk of developing heart failure (HF).This randomized controlled trial evaluated 165 patients aged 60–84 years with obesity (BMI >28kg/m²) and…
View more